Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Vaccine|August 18, 2015
Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised studyJoseph Torresi, Leon G Heron, Ming Qiao, et al.
Sexually Transmitted Infections|November 14, 2008
A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatisS Bialasiewicz, D M Whiley, M Buhrer-Skinner, et al.
Cardiovascular Research|October 24, 2013
G-protein-coupled inward rectifier potassium current contributes to ventricular repolarizationBo Liang, Jakob D Nissen, Morten Laursen, et al.
Optics Letters|June 3, 2009
Precise diffraction efficiency measurements of large-area greater-than-99%-efficient dielectric gratings at the Littrow anglePatrick P Lu, Ke-Xun Sun, Robert L Byer, et al.
Nature Communications|March 15, 2019
Fast spin exchange across a multielectron mediatorFilip K Malinowski, Frederico Martins, Thomas B Smith, et al.
Pediatrics|September 19, 2007
Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimensStephen B Lambert, Kelly M Allen, Julian D Druce, et al.
Vaccine|January 29, 2013
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adultsHelen S Marshall, Peter C Richmond, Michael D Nissen, et al.
BMJ Open|November 3, 2012
Observational Research in Childhood Infectious Diseases (ORChID): a dynamic birth cohort studyStephen Bernard Lambert, Robert S Ware, Anne L Cook, et al.
Journal of Medical Microbiology|February 16, 2013
High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platformMelanie W Syrmis, Ralf J Moser, Timothy J Kidd, et al.
The Pediatric Infectious Disease Journal|June 22, 2012
Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trialHelen S Marshall, Peter C Richmond, Michael D Nissen, et al.
Pageof 19